Point of care testing

BD has extensive research and production experience in developing near-patient testing solutions for rapidly detecting a wide range of pathogens including SARS-CoV-2, respiratory syncytial virus (RSV), influenza A+B and group A streptococcus (GAS).

BD Veritor<sup>™</sup> System for Rapid Detection of SARS-CoV-2

BD Veritor System for Rapid Detection of SARS-CoV-2

The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19

BD Veritor<sup>™</sup> Plus system

BD Veritor Plus system

The BD Veritor Plus System is a handheld device that enables testing for SARS-CoV-2, Flu A+B, Group A Strep, and respiratory syncytial virus (RSV) assays.

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

1000-BDW-EU-EN-00867

Go to top